{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T02:31:49Z","timestamp":1781490709681,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012220","name":"Hercules Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012220","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Herculesstichting","doi-asserted-by":"publisher","award":["20100225 \\u20137"],"award-info":[{"award-number":["20100225 \\u20137"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Herculesstichting","doi-asserted-by":"publisher","award":["AKUL \/09\/0035"],"award-info":[{"award-number":["AKUL \/09\/0035"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmech.2026.118597","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T07:43:36Z","timestamp":1769240616000},"page":"118597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Synthesis, structure-activity relationship study and molecular modeling of triazolo[4,5-d]pyrimidines targeting an intracellular allosteric binding site of various chemokine receptors"],"prefix":"10.1016","volume":"306","author":[{"given":"Vishnu Kavumkal","family":"Omanakuttan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathy","family":"Froeyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Claes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Van Bosstraeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrijn","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Van Meervelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Van Loy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Dehaen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3872-6558","authenticated-orcid":false,"given":"Steven","family":"De Jonghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejmech.2026.118597_bib1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ccr.2007.04.020","article-title":"Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling","volume":"11","author":"Shields","year":"2007","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.ejmech.2026.118597_bib2","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/cam4.1039","article-title":"CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial\u2013mesenchymal transition and suppressing apoptosis through AKT pathway","volume":"6","author":"Xu","year":"2017","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118597_bib3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3390\/biomedicines13041007","article-title":"The clinicopathological and prognostic value of CCR7 expression in breast cancer throughout the literature: a systematic review and meta-analysis","volume":"13","author":"Elhadary","year":"2025","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118597_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.1917484","article-title":"Targeting cancer homing into the lymph node with a novel Anti-CCR7 therapeutic antibody: the paradigm of CLL","volume":"13","author":"Cuesta-Mateos","year":"2021","journal-title":"mAbs"},{"issue":"5","key":"10.1016\/j.ejmech.2026.118597_bib5","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/hon.3213","article-title":"Evaluation of the novel therapeutic Anti-CCR7 antibody CAP-100 as an Add-on therapy in chronic lymphocytic leukemia patients receiving venetoclax","volume":"41","author":"Mateu-Albero","year":"2023","journal-title":"Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118597_bib6","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.cell.2019.07.028","article-title":"Structural basis for allosteric ligand recognition in the human CC chemokine receptor 7","volume":"178","author":"Jaeger","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.118597_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108423","article-title":"Structure-activity relationship study of Navarixin analogues as dual CXCR2 and CCR7 antagonists","volume":"159","author":"Meden","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118597_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115240","article-title":"Optimization of Triazolo[4,5-d]Pyrimidines towards human CC chemokine receptor 7 (CCR7) antagonists","volume":"251","author":"Van Hoof","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118597_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1021\/jo01071a611","article-title":"Notes- purine chemistry. VII. An improved synthesis of hypoxanthine","volume":"25","author":"Taylor","year":"1960","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.118597_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114268","article-title":"Identification of novel chemotypes as CXCR2 antagonists via a scaffold hopping approach from a Thiazolo[4,5-d]Pyrimidine","volume":"235","author":"Van Hoof","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118597_bib11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/molecules23030674","article-title":"Syntheses of 1-Aryl-5-Nitro-1H-Indazoles and a general one-pot route to 1-Aryl-1H-Indazoles","volume":"23","author":"Annor-Gyamfi","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118597_bib12","author":"Wang"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118597_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12039-024-02300-7","article-title":"Synthetic access to thiols: a review","volume":"136","author":"Monga","year":"2024","journal-title":"J. Chem. Sci."},{"issue":"24","key":"10.1016\/j.ejmech.2026.118597_bib14","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1021\/ol047996t","article-title":"A general palladium-catalyzed coupling of Aryl Bromides\/Triflates and thiols","volume":"6","author":"Itoh","year":"2004","journal-title":"Org. Lett."},{"issue":"15","key":"10.1016\/j.ejmech.2026.118597_bib15","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.bmcl.2017.06.010","article-title":"Design, synthesis and biological evaluation of novel 3H-Imidazole [4,5-b] pyridine derivatives as selective mTOR inhibitors","volume":"27","author":"Zhang","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.118597_bib16","author":"Beck"},{"issue":"0","key":"10.1016\/j.ejmech.2026.118597_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1039\/jr9600000327","article-title":"62. Potential Anti-Purines. Part III. Some 9-Dialkylamino-Alkyl-Purines and -8-Azapurines","author":"Lister","year":"1960","journal-title":"J. Chem. Soc."},{"issue":"20","key":"10.1016\/j.ejmech.2026.118597_bib18","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1021\/jm00020a017","article-title":"Synthesis and biological evaluation of N6-Cycloalkyl derivatives of 1-Deazaadenine nucleosides: a new class of anti-human immunodeficiency virus agents","volume":"38","author":"Cristalli","year":"1995","journal-title":"J. Med. Chem."},{"issue":"26","key":"10.1016\/j.ejmech.2026.118597_bib19","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1021\/jm0609622","article-title":"Discovery of 2-Hydroxy-N,N-Dimethyl-3-{2-[[(R)-1-(5- Methylfuran-2-Yl)Propyl]Amino]-3,4-Dioxocyclobut-1-Enylamino}benzamide (SCH 527123): A Potent, Orally Bioavailable CXCR2\/CXCR1 Receptor Antagonist","volume":"49","author":"Dwyer","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118597_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.855653","article-title":"A set of experimentally validated decoys for the human CC chemokine receptor 7 (CCR7) obtained by virtual screening","volume":"13","author":"Proj","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118597_bib21","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1124\/mol.107.044610","article-title":"Identification of a putative intracellular allosteric antagonist binding-site in the CXC chemokine receptors 1 and 2","volume":"74","author":"Nicholls","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118597_bib22","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1476-5381.2009.00623.x","article-title":"A common intracellular allosteric binding site for antagonists of the CXCR2 receptor","volume":"159","author":"Salchow","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"7823","key":"10.1016\/j.ejmech.2026.118597_bib23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41586-020-2492-5","article-title":"Structural basis of CXC chemokine receptor 2 activation and signalling","volume":"585","author":"Liu","year":"2020","journal-title":"Nature"},{"issue":"7633","key":"10.1016\/j.ejmech.2026.118597_bib24","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nature20605","article-title":"Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists","volume":"540","author":"Zheng","year":"2016","journal-title":"Nature"},{"issue":"7633","key":"10.1016\/j.ejmech.2026.118597_bib25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nature20606","article-title":"Intracellular allosteric antagonism of the CCR9 receptor","volume":"540","author":"Oswald","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118597_bib26","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1038\/s41467-024-52045-7","article-title":"Structural basis for CCR6 modulation by allosteric antagonists","volume":"15","author":"Wasilko","year":"2024","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118597_bib27","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.bmcl.2007.11.039","article-title":"David Nicholls, null; david Robinson, null. Evaluation of a series of bicyclic CXCR2 antagonists","volume":"18","author":"Walters","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118597_bib28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1124\/mol.113.086850","article-title":"Multiple binding sites for small-molecule antagonists at the CC chemokine receptor 2","volume":"84","author":"Zweemer","year":"2013","journal-title":"Mol. Pharmacol."},{"issue":"13","key":"10.1016\/j.ejmech.2026.118597_bib29","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118597_bib30","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"28","key":"10.1016\/j.ejmech.2026.118597_bib31","doi-asserted-by":"crossref","first-page":"7630","DOI":"10.1039\/D3SC01540H","article-title":"Semi-Enzymatic acceleration of oxidative protein folding by N-Methylated heteroaromatic thiols","volume":"14","author":"Okada","year":"2023","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.118597_bib32","author":"Zask"},{"issue":"2","key":"10.1016\/j.ejmech.2026.118597_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1107\/S0021889808042726","article-title":"OLEX2: a complete structure Solution, Refinement and Analysis Program","volume":"42","author":"Dolomanov","year":"2009","journal-title":"J Appl Cryst"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118597_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053273314026370","article-title":"SHELXT \u2013 integrated space-group and crystal-structure determination","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Cryst A"},{"key":"10.1016\/j.ejmech.2026.118597_bib35","article-title":"A kinetic fluorescence-based Ca2+ mobilization assay to identify G protein-coupled receptor agonists, antagonists, and allosteric modulators","volume":"132","author":"Claes","year":"2018","journal-title":"J. Vis. Exp."},{"issue":"W1","key":"10.1016\/j.ejmech.2026.118597_bib36","doi-asserted-by":"crossref","first-page":"W174","DOI":"10.1093\/nar\/gkv342","article-title":"I-TASSER server: new development for protein structure and function predictions","volume":"43","author":"Yang","year":"2015","journal-title":"Nucleic Acids Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:52:59Z","timestamp":1778511179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426000425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":36,"alternative-id":["S0223523426000425"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118597","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, structure-activity relationship study and molecular modeling of triazolo[4,5-d]pyrimidines targeting an intracellular allosteric binding site of various chemokine receptors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118597"}}